Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cellsResearch in context

Background: We have revealed that neuropilin-1 (NRP-1) promoted hepatic stellate cell activation and liver fibrosis through its profibrogenic signalling pathways. However, the role of NRP-1 in angiogenesis in hepatic sinusoidal endothelial cells (HSECs) during liver cirrhosis remains unclear. Method...

Full description

Bibliographic Details
Main Authors: Le Wang, Yuemin Feng, Xiaoyu Xie, Hao Wu, Xiao Nan Su, Jianni Qi, Wei Xin, Lifen Gao, Ying Zhang, Vijay H. Shah, Qiang Zhu
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396419302890
_version_ 1818015490226782208
author Le Wang
Yuemin Feng
Xiaoyu Xie
Hao Wu
Xiao Nan Su
Jianni Qi
Wei Xin
Lifen Gao
Ying Zhang
Vijay H. Shah
Qiang Zhu
author_facet Le Wang
Yuemin Feng
Xiaoyu Xie
Hao Wu
Xiao Nan Su
Jianni Qi
Wei Xin
Lifen Gao
Ying Zhang
Vijay H. Shah
Qiang Zhu
author_sort Le Wang
collection DOAJ
description Background: We have revealed that neuropilin-1 (NRP-1) promoted hepatic stellate cell activation and liver fibrosis through its profibrogenic signalling pathways. However, the role of NRP-1 in angiogenesis in hepatic sinusoidal endothelial cells (HSECs) during liver cirrhosis remains unclear. Methods: The correlation between NRP-1 expression and angiogenesis was evaluated in both human and murine cirrhotic liver tissues by immunohistochemical staining, quantitative real-time PCR, and western blotting. In addition, the role and mechanism of NRP-1 in regulating VEGFR2-dependent angiogenesis was identified in endothelial cells (ECs) in vitro. Moreover, liver histocultures were used to test the therapeutic effect of NRP-1 blocking in liver fibrosis. Findings: Higher expression of NRP-1 in HSECs was detected, which was positively correlated with angiogenesis in liver cirrhosis. In vitro, NRP-1 knockdown suppressed the expression and activation of VEGFR2, accompanied by reduced ability of the vascular tube formation and the migration of ECs. Conversely, NRP-1 overexpression upregulated VEGFR2, promoted tube formation, and the migration of ECs. Mechanistically, NRP-1 modulated the expression of VEGFR2 by regulating FAK and its kinase activity. Furthermore, NRP-1 promoted VEGFR2-dependent angiogenesis via the PI3K/Akt pathway in HSECs. Blocking NRP-1 function reduced intrahepatic angiogenesis and fibrosis-associated factors in the in vitro liver histocultures. Interpretation: NRP-1 promotes angiogenesis by upregulating the expression and activation of VEGFR2 through the PI3K/Akt signalling pathway in liver cirrhosis. This study highlights the possibility of therapeutically targeting NRP-1 for the treatment of cirrhosis. Fund: National Natural Science Foundation of China (No. 81570551; 81770607; 81600469; 81401868), Key Research project of Shandong Province (No. 2016GSF201008; 2017GSF218053), Natural Science Foundation of Shandong Province (No. ZR2017MH102), National Science and Technology Major Project of China (No. 2018ZX10302206-001-006). Keywords: Neuropilin-1, Vascular growth factor receptor 2, Hepatic sinusoidal endothelial cells, Intrahepatic angiogenesis, Cirrhosis
first_indexed 2024-04-14T06:58:41Z
format Article
id doaj.art-17b551ad4f744adcb1fe9933c7c2705d
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-04-14T06:58:41Z
publishDate 2019-05-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-17b551ad4f744adcb1fe9933c7c2705d2022-12-22T02:06:49ZengElsevierEBioMedicine2352-39642019-05-0143525536Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cellsResearch in contextLe Wang0Yuemin Feng1Xiaoyu Xie2Hao Wu3Xiao Nan Su4Jianni Qi5Wei Xin6Lifen Gao7Ying Zhang8Vijay H. Shah9Qiang Zhu10Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China; Shandong Provincial Engineering and Technological Research Center for Liver Diseases Prevention and Control, Jinan, Shandong Province, ChinaDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China; Shandong Provincial Engineering and Technological Research Center for Liver Diseases Prevention and Control, Jinan, Shandong Province, ChinaDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China; Shandong Provincial Engineering and Technological Research Center for Liver Diseases Prevention and Control, Jinan, Shandong Province, ChinaDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China; Shandong Provincial Engineering and Technological Research Center for Liver Diseases Prevention and Control, Jinan, Shandong Province, ChinaDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China; Shandong Provincial Engineering and Technological Research Center for Liver Diseases Prevention and Control, Jinan, Shandong Province, ChinaShandong Provincial Engineering and Technological Research Center for Liver Diseases Prevention and Control, Jinan, Shandong Province, China; Department of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong Province, ChinaDepartment of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong Province, ChinaKey Laboratory for Experimental Teratology of Ministry of Education, Key Laboratory for Infection and Immunity of Shandong Province, Department of Immunology School of Basic Medicine, Shandong University, Jinan, Shandong Province, ChinaDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USAGastroenterology Research Unit, Mayo Clinic and Foundation, Rochester, MN, USADepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China; Shandong Provincial Engineering and Technological Research Center for Liver Diseases Prevention and Control, Jinan, Shandong Province, China; Corresponding author at: Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, 324, Jing 5 Rd, Ji'nan 250021, Shandong Province, China.Background: We have revealed that neuropilin-1 (NRP-1) promoted hepatic stellate cell activation and liver fibrosis through its profibrogenic signalling pathways. However, the role of NRP-1 in angiogenesis in hepatic sinusoidal endothelial cells (HSECs) during liver cirrhosis remains unclear. Methods: The correlation between NRP-1 expression and angiogenesis was evaluated in both human and murine cirrhotic liver tissues by immunohistochemical staining, quantitative real-time PCR, and western blotting. In addition, the role and mechanism of NRP-1 in regulating VEGFR2-dependent angiogenesis was identified in endothelial cells (ECs) in vitro. Moreover, liver histocultures were used to test the therapeutic effect of NRP-1 blocking in liver fibrosis. Findings: Higher expression of NRP-1 in HSECs was detected, which was positively correlated with angiogenesis in liver cirrhosis. In vitro, NRP-1 knockdown suppressed the expression and activation of VEGFR2, accompanied by reduced ability of the vascular tube formation and the migration of ECs. Conversely, NRP-1 overexpression upregulated VEGFR2, promoted tube formation, and the migration of ECs. Mechanistically, NRP-1 modulated the expression of VEGFR2 by regulating FAK and its kinase activity. Furthermore, NRP-1 promoted VEGFR2-dependent angiogenesis via the PI3K/Akt pathway in HSECs. Blocking NRP-1 function reduced intrahepatic angiogenesis and fibrosis-associated factors in the in vitro liver histocultures. Interpretation: NRP-1 promotes angiogenesis by upregulating the expression and activation of VEGFR2 through the PI3K/Akt signalling pathway in liver cirrhosis. This study highlights the possibility of therapeutically targeting NRP-1 for the treatment of cirrhosis. Fund: National Natural Science Foundation of China (No. 81570551; 81770607; 81600469; 81401868), Key Research project of Shandong Province (No. 2016GSF201008; 2017GSF218053), Natural Science Foundation of Shandong Province (No. ZR2017MH102), National Science and Technology Major Project of China (No. 2018ZX10302206-001-006). Keywords: Neuropilin-1, Vascular growth factor receptor 2, Hepatic sinusoidal endothelial cells, Intrahepatic angiogenesis, Cirrhosishttp://www.sciencedirect.com/science/article/pii/S2352396419302890
spellingShingle Le Wang
Yuemin Feng
Xiaoyu Xie
Hao Wu
Xiao Nan Su
Jianni Qi
Wei Xin
Lifen Gao
Ying Zhang
Vijay H. Shah
Qiang Zhu
Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cellsResearch in context
EBioMedicine
title Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cellsResearch in context
title_full Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cellsResearch in context
title_fullStr Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cellsResearch in context
title_full_unstemmed Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cellsResearch in context
title_short Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cellsResearch in context
title_sort neuropilin 1 aggravates liver cirrhosis by promoting angiogenesis via vegfr2 dependent pi3k akt pathway in hepatic sinusoidal endothelial cellsresearch in context
url http://www.sciencedirect.com/science/article/pii/S2352396419302890
work_keys_str_mv AT lewang neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT yueminfeng neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT xiaoyuxie neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT haowu neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT xiaonansu neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT jianniqi neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT weixin neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT lifengao neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT yingzhang neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT vijayhshah neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext
AT qiangzhu neuropilin1aggravateslivercirrhosisbypromotingangiogenesisviavegfr2dependentpi3kaktpathwayinhepaticsinusoidalendothelialcellsresearchincontext